Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Fluvastatin/Valsartan in Moderate CV Risk
NCT03393377Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Sep 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of fluvastatin and valsartan in atherosclerosis (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoints: brachial flow-mediated dilatation at 30 days, reactive hyperaemia index at 30 days and 12 more. Started Sep 2014; status: completed.
02
Drugs
fluvastatinvalsartan
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT03393377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03393377.